Daiwa Securities Group
ALXO icon

Daiwa Securities Group’s ALX Oncology ALXO Stock Holding History

Daiwa Securities Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-138
Closed – – 1280
2024
Q3 		$0 Hold
138
– – ﹤0.01% 1277
2024
Q2 		$1K Hold
138
– – ﹤0.01% 1278
2024
Q1 		$2K Hold
138
– – ﹤0.01% 1257
2023
Q4 		$2K Hold
138
– – ﹤0.01% 1262
2023
Q3 		$1K Hold
138
– – ﹤0.01% 1235
2023
Q2 		$1K Hold
138
– – ﹤0.01% 1258
2023
Q1 		$1K Hold
138
– – ﹤0.01% 1239
2022
Q4 		$2K Hold
138
– – ﹤0.01% 1209
2022
Q3 		$1K Hold
138
– – ﹤0.01% 1267
2022
Q2 		$1K Hold
138
– – ﹤0.01% 1275
2022
Q1 		$2K Hold
138
– – ﹤0.01% 1239
2021
Q4 		$3K Hold
138
– – ﹤0.01% 1235
2021
Q3 		$10K Buy
138
+59
+75% +$3.93K ﹤0.01% 1136
2021
Q2 		$4K Hold
79
– – ﹤0.01% 1082
2021
Q1 		$6K Buy
79
+9
+13% +$708 ﹤0.01% 1066
2020
Q4 		$6K Buy
+70
New +$4.21K ﹤0.01% 1043

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Daiwa Securities Group's ALXO Position: Q4 2024 in Review

Daiwa Securities Group sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 138 shares.

Daiwa Securities Group first reported a position in ALXO in Q4 2020 and held it in 16 quarters. The position peaked at $10K in Q3 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Daiwa Securities Group reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 138 ALX Oncology shares in Q4 2024.
  • Daiwa Securities Group first reported a position in ALX Oncology in Q4 2020 and held it in 16 quarters.
  • Daiwa Securities Group's ALX Oncology position peaked at $10K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.